-
HR 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
6 filings
-
S 1032
Major Richard Star Act
6 filings
-
S 1040
Drug Competition Enhancement Act
6 filings
-
S 1041
Affordable Prescriptions for Patients Act
6 filings
-
S 1095
Stop STALLING Act
6 filings
-
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
6 filings
-
S 1097
Interagency Patent Coordination and Improvement Act of 2025
6 filings
-
S 229
DTC Act of 2025
6 filings
-
S 43
Skinny Labels, Big Savings Act
6 filings
-
HR 3010
No Handouts for Drug Advertisements Act
5 filings
-
HR 3152
Patent Eligibility Restoration Act of 2025
5 filings
-
HR 3160
PREVAIL Act
5 filings
-
S 1533
A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contr…
5 filings
-
S 1546
Patent Eligibility Restoration Act of 2025
5 filings
-
S 1785
No Handouts for Drug Advertisements Act
5 filings
-
S 1954
Biosimilar Red Tape Elimination Act
5 filings
-
HR 3269
ETHIC Act
4 filings
-
HR 3789
DTC Act of 2025
4 filings
-
HR 4570
Interagency Patent Coordination and Improvement Act of 2025
4 filings
-
HR 5526
Biosimilar Red Tape Elimination Act
4 filings
-
S 2276
ETHIC Act
4 filings
-
S 2630
Saving NSF’s Workforce Act
4 filings
-
S 2658
Medication Affordability and Patent Integrity Act
4 filings
-
HR 1262
Mikaela Naylon Give Kids a Chance Act
3 filings
-
HR 6485
Skinny Labels, Big Savings Act
3 filings
-
S 1414
Expedited Access to Biosimilars Act
2 filings
-
S 3014
Ensuring Timely Access to Generics Act of 2025
2 filings
-
S 5573
Skinny Labels, Big Savings Act
1 filing
-
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
1 filing